JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M801762200 on May 22, 2008

J. Biol. Chem., Vol. 283, Issue 29, 19904-19911, July 18, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/29/19904    most recent
M801762200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Mantuano, E.
Right arrow Articles by Gonias, S. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mantuano, E.
Right arrow Articles by Gonias, S. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular Dissection of the Human {alpha}2-Macroglobulin Subunit Reveals Domains with Antagonistic Activities in Cell Signaling*

Elisabetta Mantuano, Gatambwa Mukandala, Xiaoqing Li, W. Marie Campana, and Steven L. Gonias1

From the Departments of Pathology and Anesthesiology, University of California, San Diego, La Jolla, California 92093

{alpha}2-Macroglobulin ({alpha}2M) is a plasma protease inhibitor, which reversibly binds growth factors and, in its activated form, binds to low density lipoprotein receptor-related protein (LRP-1), an endocytic receptor with cell signaling activity. Because distinct domains in {alpha}2M are responsible for its various functions, we hypothesized that the overall effects of {alpha}2M on cell physiology reflect the integrated activities of multiple domains, some of which may be antagonistic. To test this hypothesis, we expressed the growth factor carrier site and the LRP-1 recognition domain (RBD) as separate GST fusion proteins (FP3 and FP6, respectively). FP6 rapidly and robustly activated Akt and ERK/MAP kinase in Schwann cells and PC12 cells. This response was blocked by LRP-1 gene silencing or by co-incubation with the LRP-1 antagonist, receptor-associated protein. The activity of FP6 also was blocked by mutating Lys1370 and Lys1374, which precludes LRP-1 binding. FP3 blocked activation of Akt and ERK/MAP kinase in response to nerve growth factor-β (NGF-β) but not FP6. In PC12 cells, FP6 promoted neurite outgrowth and expression of growth-associated protein-43, whereas FP3 antagonized the same responses when NGF-β was added. The ability of FP6 to trigger LRP-1-dependent cell signaling in PC12 cells was reproduced by the 18-kDa RBD, isolated from plasma-purified {alpha}2M by proteolysis and chromatography. We propose that the effects of intact {alpha}2M on cell physiology reflect the degree of penetration of activities associated with different domains, such as FP3 and FP6, which may be regulated asynchronously by conformational change and by other regulatory proteins in the cellular microenvironment.


Received for publication, March 5, 2008 , and in revised form, May 8, 2008.

* This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS-054671, R01 HL-60551, and R01 NS-057456. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: UCSD School of Medicine, Dept. of Pathology, 9500 Gilman Dr., La Jolla, CA 92093-0612. Tel.: 858-534-1887; Fax: 858-534-0414; E-mail: sgonias{at}ucsd.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.